Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07895420
PHASE4

Comparing Intravitreal Injection Pain Scores Using Iheezo (Chloroprocaine Hcl Ophthalmic Gel 3%) Versus Subconjunctival Lidocaine (2%): A Randomized, Controlled Trial

Sponsor: Retina Research Institute, LLC

View on ClinicalTrials.gov

Summary

This will be a prospective, randomized, controlled non-inferiority trial comparing the efficacy of Iheezo versus subconjunctival 2% lidocaine in reducing intravitreal injection pain scores up to 24 hours after injection.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2025-10-30

Completion Date

2026-12-30

Last Updated

2026-10-26

Healthy Volunteers

No

Conditions

Interventions

DRUG

chloroprocaine HCL 3%

Topical anesthetic for intravitreal injection

DRUG

Subconjunctival Lidocaine

Procedural anesthetic for intravitreal injection

Locations (4)

The Retina Institute

Glen Carbon, Illinois, United States

The Retina Institute

Chesterfield, Missouri, United States

The Retina Institute

City of Saint Peters, Missouri, United States

The Retina Institute

St Louis, Missouri, United States